Avenue Therapeutics (ATXI) Cash & Equivalents (2016 - 2026)
Avenue Therapeutics' Cash & Equivalents came in at $1.94 million for Q2 2026, down 41.6% from $3.33 million a year earlier and down 19.7% from the prior quarter.
Powered by 
Analysis
Avenue Therapeutics (ATXI) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Avenue Therapeutics' Cash & Equivalents was $2.86 million, up 10.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $2.59 million in FY2024 (+45.5%), $1.78 million in FY2023 (-73.4%), $6.71 million in FY2022 (+78.3%) and $3.76 million in FY2021 (+20.1%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q4 2023.
- Year-over-year, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 0.4%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2023 (growth of 349.3%), and the weakest in Q3 2021 (a decline of 86.1%).
- Business Quant data shows ATXI's Cash & Equivalents at $2.42 million (Q1 2026), $2.86 million (Q4 2025) and $3.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Avenue Therapeutics | 1.32 Mn | -9.61 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 4.92 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 161,000.00 |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 217,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 600,000.00 |
API Access
Avenue Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATXI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ATXI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATXI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();